Market Cap: $79.18B
RI
Regeneron Pharmaceuticals, Inc.
REGN
NASDAQ (NASDAQ Global Select)USD
Market Cap: $79.18B
Analysts estimated REGN earnings of $10.47 per share this quarter (Q2). REGN's actual earnings were $14.29 per share.
REGN EPS surprise of 36.51%Analysts estimated REGN earnings of $10.83 per share this quarter (Q4). REGN's actual earnings were $11.44 per share.
REGN EPS surprise of 5.65%Analysts estimated REGN earnings of $9.78 per share this quarter (Q3). REGN's actual earnings were $11.83 per share.
REGN EPS surprise of 20.96%Analysts estimated REGN earnings of $8.61 per share this quarter (Q2). REGN's actual earnings were $12.89 per share.
REGN EPS surprise of 49.77%Analysts estimated REGN earnings of $9.00 per share this quarter (Q1). REGN's actual earnings were $8.22 per share.
REGN EPS surprise of 9.48%Analysts estimated REGN earnings of $10.83 per share this quarter (Q2). REGN's actual earnings were $11.56 per share.
REGN EPS surprise of 6.79%Analysts estimated REGN earnings of $10.29 per share this quarter (Q1). REGN's actual earnings were $9.55 per share.
REGN EPS surprise of 7.79%Analysts estimated REGN earnings of $10.95 per share this quarter (Q4). REGN's actual earnings were $11.86 per share.
REGN EPS surprise of 8.36%